About

Mike Jones is the Director of Web & Automation Technologies at USC Libraries. In this role, he spearheads the development and implementation of strategic initiatives for web and artificial intelligence (AI) projects and services. With 20 years of experience managing complex projects and leading interdisciplinary teams, including over nine years specifically in an academic library setting, Mike brings a wealth of expertise to his position. His extensive background includes major redesigns of websites and applications and the development and launch of new technology-based services. Notably, Mike led the development of the USC Interactive Interviews service, which incorporates conversational AI to enhance access to and engagement with oral histories. His current focus is on developing generative AI workshops, resources, and applications in an academically-sound manner to modernize and enhance research and scholarship at USC Libraries and across the university.

Research topics

• Dermatology
• Medicine
• Internal medicine
• Virology
• Physical therapy
• Surgery
• Intensive care medicine
• Immunology

Selected publications

• Common Causes of Hypopigmentation in Children

  Pediatrics in Review · 2025-10-01 · 1 citations

  review

  Disorders of hypopigmentation are relatively common in children. Hypopigmentation refers to decreased pigmentation compared with surrounding skin, and depigmentation refers to a complete loss of pigmentation. The most common acquired causes include post-inflammatory hypopigmentation, pityriasis alba, vitiligo, tinea versicolor, and halo nevi. Commonly, congenital hypopigmented lesions may be attributed to pigmentary mosaicism, a term that refers to hypo- or hyperpigmentation resulting from somatic mosaicism. Pigmentary mosaicism most commonly occurs without syndromic association, such as in the case of nevus depigmentosus; however, rarely it can occur as part of a syndrome that may require further workup with genetic testing, such as with the hypomelanotic macules of tuberous sclerosis complex. Although most of the conditions causing hypopigmentation and depigmentation in children are benign, rare instances may be associated with syndromes or rare dermatoses that require further workup by a specialist. Given their common presentation to the general pediatrician, this article aims to cover the most common causes of hypo- and depigmentation in children, along with their differentiating features, natural history and prognosis, first-line treatment, and indications for further evaluation.

  PublisherDOI

• Acute Liver Failure and a Rash

  Gastroenterology · 2025-01-31 · 2 citations

  article
  PublisherDOI

• Treatment outcomes in 63 cases of juvenile dermatomyositis-associated calcinosis

  Clinical and Experimental Rheumatology · 2024-10-31 · 1 citations

  articleOpen access

  OBJECTIVES: We performed a multi-institutional retrospective review of patients treated for juvenile dermatomyositis (JDM)-associated calcinosis to analyse the association between treatment outcomes and patient, disease, and treatment characteristics. METHODS: Childhood Arthritis and Rheumatology Research Alliance investigators searched their electronic health records for patients with JDM and calcinosis treated between 2003 and 2019 and analysed data at JDM diagnosis, calcinosis diagnosis, and calcinosis treatment. Statistical methods included univariable and multivariable analyses, Kaplan-Meier estimates, and multivariable Cox models. RESULTS: Data were collected for 63 patients from 11 institutions. Median (IQR) age was 7.8 (4.1-11.1) years at JDM diagnosis and 9.4 (5.7-13.3) years at calcinosis diagnosis. Calcinosis was present at JDM diagnosis in 32% of patients (n=20). JDM was active in 76% of patients (47/62) at calcinosis diagnosis. Anti-nuclear matrix protein 2 (anti-NXP2) antibody was the most commonly detected myositis autoantibody (38%, 12/32). The presence of anti-NXP2 or anti-melanoma differentiation-associated gene 5 autoantibody did not significantly affect the probability of any calcinosis improvement (p=0.30). Patients received 103 unique treatment regimens of immunomodulatory agents with or without calcium-modifying agents, but those who received both had the greatest probability of improvement. Intravenous immunoglobulin (IVIG) was associated with a significantly higher probability of calcinosis improvement (p=0.02) than treatments without IVIG. Overall, 79% of patients (n=50) showed improved calcinosis. CONCLUSIONS: Despite wide variations in treatment, many patients showed calcinosis improvement over time, especially those treated with IVIG. Studies using validated outcomes assessments may be needed to develop effective treatment plans for JDM-associated calcinosis.

  PublisherOA PDFDOI

• 43060 A dermatologist, internist, and family medicine physician walk into an eczema patient visit: Comparing systemic corticosteroid prescribing patterns between dermatologists and primary care providers for AD

  Journal of the American Academy of Dermatology · 2023-09-01

  articleOpen access
  PublisherOA PDFDOI

• Complete Genome Sequences of <i>Microbacterium</i> Phages Clayda5 and Gshelby23 and <i>Gordonia</i> Phages Wrigley and Santhid

  Microbiology Resource Announcements · 2022-10-10

  articleOpen access

  Bacteriophages Clayda5, Gshelby23, Wrigley, and Santhid were isolated from soil samples collected in Iowa, with genomes typical of actinobacteriophages from clusters EB, EM, CY, and DY, respectively. Wrigley and Santhid were isolated on Gordonia terrae and are likely to be temperate. Clayda5 and Gshelby23 were isolated on Microbacterium foliorum.

  PublisherDOI

• 34554 “Nothing really seemed to touch it that wasn’t a steroid”: An analysis of social media posts regarding the efficacy of topical corticosteroid use in atopic dermatitis

  Journal of the American Academy of Dermatology · 2022-09-01

  article
  PublisherDOI

• 236 Opiate use in dermatology in the United States: A population-based study using the national ambulatory medical care survey

  Journal of Investigative Dermatology · 2021-04-19

  articleOpen access
  PublisherOA PDFDOI

• 240 Differences in acne therapy prescribing patterns between pediatricians and dermatologists

  Journal of Investigative Dermatology · 2021-04-19

  articleOpen access1st authorCorresponding
  PublisherOA PDFDOI

• Trichotillomania in the United States: An epidemiologic study of patient characteristics, comorbidities, and treatment patterns

  Dermatology Online Journal · 2021-09-29

  articleOpen access
  PublisherOA PDFDOI

• Topical opioid use in dermatologic disease: A systematic review

  Dermatologic Therapy · 2021 · 9 citations

  • Medicine
  • Dermatology
  • Surgery

  Topical opioid formulations offer a potential solution to manage pain and decrease the use of systemic opioids. Synthesis of use and efficacy of topical opioids in dermatological conditions has not been well characterized. We conducted a systematic search of the PubMed, Embase, and Cochrane databases from 1980 to February 2021. This study analyzed data from 14 articles and 263 patients on the use of topical opioids for pain related to chronic ulcers, burns, oral lichen planus, photodynamic therapy, and split-thickness skin grafts. Topical opioids included in this review were topical morphine and diamorphine. Common formulations consisted of 0.2-10 mg of opioid compounded with hydrogel or IntraSite gel. Topical opioids were variably effective in the use for pain control related to chronic ulcers and other dermatologic conditions. For example, the use of topical opioids appears to be effective in the reduction of pain related to pressure ulcers. Topical opioids were generally well tolerated. Insufficient data exist to adequately evaluate the efficacy and safety of topical opioid use in the context of nonpressure ulcers, burns, oral lichen planus, photodynamic therapy, and split-thickness skin grafts.

  PublisherDOI

Frequent coauthors

• Jeffrey R. Rajkumar

  University of Illinois Chicago

  16 shared

• Sarah P. Pourali

  Vanderbilt University

  13 shared

• Yasmin Gutierrez

  12 shared

• April W. Armstrong

  University of California, Los Angeles

  12 shared

• A Kohn

  8 shared

• Alison H. Kucharik

  University of South Florida

  5 shared

• April W. Armstrong

  University of California, Los Angeles

  3 shared

• Gina Kostandy

  University of Southern California

  2 shared